Administration of GIP to high-fat-diet-treated mice increased blood levels of leptin, an anti-obesity hormone [25], while administration of tirzepatide in obese mice enhanced the influx of branched-chain amino acids into brown adipose tissue and stimulated thermogenic signaling [26]. Here, GIP is linked to obesity due to melanocortin 4 receptor deficiency.